[Sulodexide treatment in retinal vein obstructions].

Retinal vein occlusion (RVO) represents one of the most frequent vascular disorders of the posterior pole. RVO treatment is disappointing because a great number of patients remains with a reduced visual acuity; the visual acuity is the functional test which shows the treatment efficacity. The study group of patients was treated with sulodexid, a therapeutic agent with thrombolytic and fibrinolytic action; sulodexid was associated with laser photocoagulation where it was required. Study's results point out efficiency only for those cases treated precociously between 48 to 72 hours from the outset.